Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment-Reference-Cited by-同舟云学术

Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment

Published:2022-10 Issue:5 Volume:7 Page:100588
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Aamdal E.^ORCID,Skovlund E.,Jacobsen K.D.,Straume O.,Kersten C.,Herlofsen O.,Karlsen J.,Hussain I.,Amundsen A.,Dalhaug A.,Nyakas M.,Hagene K.T.,Holmsen K.,Aamdal S.,Kaasa S.,Guren T.K.,Kyte J.A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Michielin;Ann Oncol,2019

3. Determinants of quality of life in patients with incurable cancer;Daly;Cancer,2020

4. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology;Aaronson;J Natl Cancer Inst,1993

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Comparison of Health-Related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients;Journal of Clinical Medicine;2024-08-20

2. The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2024-07

3. For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic Therapy;Current Oncology Reports;2024-05-23

4. Side effects, quality of life, and treatment adherence in melanoma patients undergoing systemic therapy;Die Onkologie;2023-07-05